FDA Approved: IDARUBICIN HYDROCHLORIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for idarubicin hydrochloride from Meitheal Pharmaceuticals Inc., authorizing a generic version under ANDA 065036.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Idarubicin hydrochloride (idarubicin hydrochloride)

Snippet

SUPPL AP for IDARUBICIN HYDROCHLORIDE (IDARUBICIN HYDROCHLORIDE)